Bodal Chemicals Ltd
Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]
- Market Cap ₹ 897 Cr.
- Current Price ₹ 71.2
- High / Low ₹ 81.9 / 41.2
- Stock P/E 19.0
- Book Value ₹ 95.2
- Dividend Yield 0.00 %
- ROCE 6.77 %
- ROE 4.00 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.75 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.8% over past five years.
- Company has a low return on equity of 2.00% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments
Part of BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,043 | 907 | 1,182 | 1,121 | 1,379 | 1,224 | 1,130 | 2,011 | 1,555 | 1,386 | 1,723 | 1,975 | |
| 859 | 758 | 961 | 924 | 1,146 | 1,091 | 1,047 | 1,787 | 1,434 | 1,279 | 1,557 | 1,807 | |
| Operating Profit | 184 | 150 | 221 | 197 | 233 | 133 | 83 | 224 | 121 | 108 | 166 | 168 |
| OPM % | 18% | 17% | 19% | 18% | 17% | 11% | 7% | 11% | 8% | 8% | 10% | 8% |
| 5 | 20 | 15 | 12 | 15 | 14 | 18 | 8 | 8 | 15 | 8 | 39 | |
| Interest | 27 | 12 | 7 | 5 | 7 | 14 | 9 | 21 | 34 | 52 | 80 | 79 |
| Depreciation | 22 | 26 | 26 | 11 | 18 | 26 | 28 | 46 | 52 | 60 | 68 | 69 |
| Profit before tax | 139 | 132 | 203 | 193 | 222 | 106 | 64 | 165 | 43 | 12 | 27 | 59 |
| Tax % | 34% | 34% | 35% | 34% | 35% | 15% | 24% | 25% | 27% | 35% | 26% | 20% |
| 92 | 87 | 133 | 128 | 144 | 90 | 48 | 124 | 31 | 8 | 20 | 47 | |
| EPS in Rs | 8.43 | 7.94 | 12.18 | 10.44 | 11.79 | 7.37 | 3.95 | 10.15 | 2.48 | 0.61 | 1.55 | 3.73 |
| Dividend Payout % | 0% | 8% | 7% | 8% | 7% | 11% | 20% | 8% | 4% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 12% |
| 3 Years: | 8% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -1% |
| 3 Years: | 16% |
| TTM: | 131% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -8% |
| 3 Years: | 2% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 4% |
| 3 Years: | 2% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 |
| Reserves | 139 | 218 | 341 | 678 | 811 | 912 | 968 | 1,078 | 1,101 | 1,108 | 1,127 | 1,173 |
| 234 | 143 | 142 | 148 | 135 | 238 | 436 | 640 | 755 | 903 | 911 | 813 | |
| 145 | 132 | 187 | 191 | 265 | 249 | 279 | 384 | 281 | 300 | 333 | 378 | |
| Total Liabilities | 539 | 514 | 692 | 1,041 | 1,235 | 1,424 | 1,708 | 2,127 | 2,163 | 2,336 | 2,396 | 2,390 |
| 190 | 184 | 196 | 412 | 529 | 613 | 760 | 804 | 955 | 1,302 | 1,291 | 1,229 | |
| CWIP | 3 | 0 | 9 | 14 | 20 | 1 | 4 | 70 | 193 | 68 | 61 | 67 |
| Investments | 3 | 3 | 21 | 24 | 20 | 41 | 44 | 99 | 100 | 113 | 101 | 101 |
| 343 | 326 | 465 | 591 | 666 | 770 | 899 | 1,155 | 914 | 852 | 943 | 993 | |
| Total Assets | 539 | 514 | 692 | 1,041 | 1,235 | 1,424 | 1,708 | 2,127 | 2,163 | 2,336 | 2,396 | 2,390 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 198 | 133 | 112 | 22 | 210 | 65 | -22 | 30 | 246 | 191 | 106 | 177 | |
| -35 | -24 | -100 | -216 | -175 | -146 | -171 | -194 | -315 | -266 | -39 | 8 | |
| -162 | -109 | -9 | 191 | -29 | 86 | 186 | 162 | 69 | 88 | -71 | -191 | |
| Net Cash Flow | 0 | -1 | 3 | -3 | 6 | 6 | -6 | -2 | 1 | 14 | -5 | -6 |
| Free Cash Flow | 162 | 116 | 62 | -197 | 67 | 16 | -187 | -127 | -72 | -42 | 62 | 182 |
| CFO/OP | 129% | 112% | 82% | 41% | 117% | 63% | -16% | 30% | 209% | 174% | 60% | 106% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 67 | 56 | 89 | 77 | 111 | 128 | 98 | 95 | 99 | 84 | 79 |
| Inventory Days | 43 | 56 | 57 | 58 | 77 | 90 | 126 | 141 | 112 | 128 | 134 | 104 |
| Days Payable | 62 | 67 | 75 | 77 | 80 | 92 | 101 | 83 | 76 | 101 | 98 | 82 |
| Cash Conversion Cycle | 50 | 56 | 39 | 70 | 74 | 109 | 152 | 155 | 131 | 126 | 120 | 101 |
| Working Capital Days | 23 | 17 | 18 | 65 | 45 | 46 | 51 | 51 | 43 | 12 | 16 | 24 |
| ROCE % | 39% | 35% | 46% | 29% | 25% | 11% | 6% | 11% | 4% | 3% | 5% | 7% |
Insights
In beta| Sep 2020 | |
|---|---|
| Total Production Volume (Bodal Chemicals) Metric Tonnes |
|
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Bodal Chemicals Limited herewith submit news paper publication for IEPF advertisement notice.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
22 May - Bodal Chemicals Limited herewith submit newspaper publication
-
Announcement - Declaration Of Unmodified Opinion Of Audited Financial Results For Year Ended 31St March 2026
21 May - Bodal Chemicals submitted declaration for unmodified audit opinion on FY26 audited results.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May - Bodal Chemicals Limited herewith inform Exchange about Earning Presentation for Q4 - May 2026
-
Board Meeting Outcome for Outcome Of Board Meeting
21 May - Board approved FY26 audited results and sale of inoperative Unit I at market rates.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020TranscriptAI SummaryPPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Mar 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019Transcript PPT
-
May 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Mar 2019TranscriptAI SummaryPPT
-
Mar 2019TranscriptAI SummaryPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Oct 2018TranscriptAI SummaryPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptAI SummaryPPT
-
Jun 2018Transcript PPT
-
Jun 2018Transcript PPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptAI SummaryPPT
-
Dec 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Mar 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptAI SummaryPPT
-
Nov 2016Transcript PPT
-
Aug 2016TranscriptAI SummaryPPT
-
Jun 2016TranscriptAI SummaryPPT
-
Feb 2016TranscriptAI SummaryPPT
Product Portfolio:[1]
a) Basic Chemicals (~12 Products): Sulphuric Acid, Chlorosulphonic Acid, Sulphur Trioxide, Oleum 23% & 65%, Sodium Bisulphate, Acetanilide, Thionyl Chloride, Beta Naphthol, Para Nitro Aniline.
b) Dye Intermediates (~25 Products):
Vinyl Sulphone & Derivatives, H Acid, DASA, F.C. Acid, Gamma Acid, K Acid, Sulpho Tobias Acid, 4.N.A.D.P.S.A, 6-Nitro, MPDSA, Meta Ureido Aniline, 1:2:4 DIAZO
c) Dyestuffs (~175 Products):
Reactive Dyes, Acid Dyes, Direct Dyes, Liquid Dyes
d) Chlor Alkali (~6 Products):
Caustic Soda, Chlorine, Hydrogen, Hydrochloric Acid (HCL), Sodium Hypochlorite (HYPO), Stable Bleaching Powder (SBP)